References
- Hitchcock LS, Ferrell BR, McCafferty M. The experience of continuous non-cancer pain. J Pain Symptom Manage 1994;9:312–8
- Holman GH. Chronic nonmalignant pain. Clin Geriatr 1997;5:21–41
- Arthritis Research Campaign. Factfile – arthritis at a glance. Arthritis Research Campaign, Chesterfield, 2002. Available from: http://www.arc.org.uk/about_arth/astats.htm [accessed 19 October 2004]
- Anderson KO, Bradley LA, Turner RA, Agudelo CA, Pisko EJ. Pain behaviour of rheumatoid arthritis patients enrolled in experimental drug trials. Arthritis Care Res 1994;7:64–8
- Buckelew SP, Parker JC. Coping with arthritis pain: a review of the literature. Arthritis Care Res 1989;2:136–45
- Creamer P, Hochberg MC. Osteoarthritis. Lancet 1997;350:503–8
- Pinals RS. Mechanism of joint destruction, pain and disability in osteoarthritis. Drugs 1996;52\(Supp 3):14–20
- Wolheim FA. Current pharmacological treatment of osteroarthritis. Drugs 1996;52\(Supp3):27–38
- Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. New Engl J Med 1984;310:563–72
- Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. New Engl J Med 1994;331:1675–9
- Johnson AG, Nguyen TV, Day RO. Do non-steroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289–300
- Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307–14
- Garcia Rodriguez LA, Hernander-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12:570–6
- McQuay H. Opioids in pain management. Lancet 1999;353:2229–32
- Jadad A, Carroll D, Glynn C, Moore RA, McQuay HJ. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet 1992;339:1367–71
- Arkinstall W, Sandler A, Goughnour B, et al. Efficacy of controlled release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995;62: 169–78
- Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143–7
- Dellemijn PLI, Vanneste JAL. Randomized double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997;349:753–8
- Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50:1837–41
- Peloso PM, Bellamy N, Bensen W, et al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the knee or hip. J Rheumatol 2000;27:764–71
- Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: a double blind, randomized, multicentre, placebo controlled trial. J Rheumatol 1999;26: 862–9
- Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278–91
- Gonzales GR, Portenoy RK. Selection of analgesic therapies in rheumatoid arthritis: role of opioid medications. Arthritis Care Res 1993;6:223–8
- Griessinger N, Sittl R, Jost R, Schaefer M, Likar R. The role of opioid analgesics in rheumatoid disease in the elderly population. Drugs Aging 2003;20:571–83
- Kalso E, Allan L, Dellemijn PLI, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003;7:381–6
- Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936–44
- American Pain Society. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. American Pain Society, Glenview, IL, 2002. Available from: http://www.ampainsoc.org/pub/arthritis.htm [accessed 19 October 2004]
- Schug SA, Merry AF, Acland RH. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 1991;42:228–39
- Graziotti PJ, Goucke CR. The use of oral opioids in patients with chronic non-cancer pain. Management strategies. Med J Aust 1997;167:30–4
- Anon. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Pain Forum 1997;6:77–9
- Jeal W, Benfield P. Transdermal fentanyl: a review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997;53:109–38
- Simpson RK, Edmondson EA, Constant CF, Collier C. Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage 1997;14:218–24
- Allen L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br Med J 2001;322:1154–8
- Milligan K, Lanteri-Minet M, Borchert K, et al. Evaluation of long term efficacy and safety of transdermal fentanyl in the treatment of chronic non-cancer pain. J Pain 2001;2:197–204
- Ringe JD, Faber H, Bock O, et al. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int 2002;22:199–203
- Theodoridis T, Waap I, Schwalen S, Kramer J. Fentanyl in the treatment of pain caused by arthrosis. Z Orthop 2002;140:217–22
- Berliner M, Schwalen S, Seidel W, Hantzschel H. Fentanyl-TTS in the treatment of pain caused by rheumatoid arthritis. Akt Rheumatol 2002;27:230–5
- Arnett FC, Edworthy SM, Bloch DA, et al. The Americam Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24
- Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis, part I: osteoarthritis of the hip. Arthritis Rheum 1995;38:1535–40
- Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis, part II: osteoarthritis of the knee. Arthritis Rheum 1995;38:1541–6
- Bierma-Zeinstra S, Bohnen A, Ginai A, Prins A, Verhaar J. Validity of the American College of Rheumatology criteria for diagnosing hip osteoarthritis in primary care research. J Rheumatol 1999;26:1129–33
- Bellamy N, Bradley LA. Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1996;39:357–62
- Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–38
- Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). Med Care 1992;30:473–83
- Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patients outcome in arthritis. Arthritis Rheum 1980;23:137–45
- Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the knee or hip. J Rheumatol 1988;15:1833–40
- Gillings D, Koch G. The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Inform J 1991;25:411–24
- Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000;19:S16–S20
- Wang SC. Emetic and antiemetic drugs. In: Root WS, Hofmann FG, editors. Physiological pharmacology II. New York: Academic Press; 1965. p. 255–328
- Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy and quality of life. J Pain Symptom Manage 1997;13:254–61
- Allan LA, Kalso E, on behalf of the FEN-INT-26 Study Group. Randomised trial of transdermal fentanyl and sustained release oral morphine in chronic low back pain. Presented at the 4th Congress EFIC, Czech Republic, Prague, 2–6 September 2003
- Knott L. Treating osteoarthritis in practice – the TOP study. Curr Med Res Opin 2000;16:147–52
- Portenoy RK. Opioid therapy for nonmalignant pain: a clinician’s perspective. J Law Med Ethics 1996;24:296–309